PROMETHAZINE Rx-TO-OTC SWITCH SHOULD NOT BE ALLOWED, FDA ADVISORY PANEL RECOMMENDS; PANEL CONCERNED OVER ASSOCIATION WITH SIDS AND PRESCRIBING ABUSE

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".